tetano
Editor, Senior Moderator
Hum Vaccin Immunother
. 2020 Aug 12;1-22.
doi: 10.1080/21645515.2020.1797369. Online ahead of print.
Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
Mohamad Hesam Shahrajabian[SUP] 1 [/SUP], Wenli Sun[SUP] 1 [/SUP], Qi Cheng[SUP] 1 2 3 [/SUP]
Affiliations
Abstract
SARS-CoV-2, the virus causing COVID-19, is a single-stranded RNA virus belonging to the order Nidovirales, family Coronaviridae, and subfamily Coronavirinae. SARS-CoV-2 entry to cellsis initiated by the binding of the viral spike protein (S) to its cellular receptor. The roles of S protein in receptor binding and membrane fusion makes it a prominent target for vaccine development. SARS-CoV-2 genome sequence analysis has shown that this virus belongs to the beta-coronavirus genus, which includes Bat SARS-like coronavirus, SARS-CoV and MERS-CoV. A vaccine should induce a balanced immune response to elicit protective immunity. In this review, we compare and contrast these three important CoV diseases and how they inform on vaccine development.
Keywords: MERS; SARS; SARS-CoV-2; coronaviruses; emerging diseases; pneumonia.
. 2020 Aug 12;1-22.
doi: 10.1080/21645515.2020.1797369. Online ahead of print.
Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
Mohamad Hesam Shahrajabian[SUP] 1 [/SUP], Wenli Sun[SUP] 1 [/SUP], Qi Cheng[SUP] 1 2 3 [/SUP]
Affiliations
- PMID: 32783700
- DOI: 10.1080/21645515.2020.1797369
Abstract
SARS-CoV-2, the virus causing COVID-19, is a single-stranded RNA virus belonging to the order Nidovirales, family Coronaviridae, and subfamily Coronavirinae. SARS-CoV-2 entry to cellsis initiated by the binding of the viral spike protein (S) to its cellular receptor. The roles of S protein in receptor binding and membrane fusion makes it a prominent target for vaccine development. SARS-CoV-2 genome sequence analysis has shown that this virus belongs to the beta-coronavirus genus, which includes Bat SARS-like coronavirus, SARS-CoV and MERS-CoV. A vaccine should induce a balanced immune response to elicit protective immunity. In this review, we compare and contrast these three important CoV diseases and how they inform on vaccine development.
Keywords: MERS; SARS; SARS-CoV-2; coronaviruses; emerging diseases; pneumonia.